Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.17 USD
Change Today +0.03 / 2.63%
Volume 24.0K
As of 8:10 PM 10/5/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

767 Fifth Avenue

New York, NY 10153

United States

Phone: 212-702-4300


Cadus Corporation focuses on real estate acquisition, renovation, and construction activities in Florida. As of March 15, 2015, the company had purchased and continues to own 12 single-family residential zoned properties in Miami-Dade County, Florida. The lots for these properties range from approximately 7,500 to approximately 18,400 square feet, with an average lot size of approximately 15,000 square feet and with most of the lots having an area of approximately 12,000 square feet. When individual homes are purchased, the company intends, as appropriate, to renovate them for resale or to demolish them for new home construction. When vacant lots are purchased, the company intends to construct new homes on them for sale. In some cases, the company might also acquire partially constructed or renovated homes for completion and resale or resell acquired homes or land without undertaking renovation or construction. The company has a wholly owned subsidiary, Cadus Technologies, Inc. (Cadus Technologies), which holds all patents, patent applications, know how, licenses and drug discovery technologies of the company. As of March 1, 2015, Cadus Technologies is the assignee of 16 issued U.S. patents covering aspects of its yeast technology and is the exclusive worldwide licensee of one issued U.S. patent for use in drug discovery. History The company was founded in 1992. It was incorporated under the laws of the state of Delaware in 1992. The company was formerly known as Cadus Pharmaceutical Corporation and changed its name to Cadus Corporation in 2003.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KDUS:US $1.17 USD +0.03

KDUS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KDUS.
View Industry Companies

Industry Analysis


Industry Average

Valuation KDUS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CADUS CORP, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at